Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
55.92 USD | +0.22% | +0.79% | +24.46% |
04-12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
04-08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Sales 2024 * | 4.4B 6.01B | Sales 2025 * | 4.66B 6.36B | Capitalization | 10.12B 13.83B |
---|---|---|---|---|---|
Net income 2024 * | -816M -1.12B | Net income 2025 * | 78M 107M | EV / Sales 2024 * | 3.38 x |
Net Debt 2024 * | 4.74B 6.48B | Net Debt 2025 * | 4.4B 6.01B | EV / Sales 2025 * | 3.12 x |
P/E ratio 2024 * |
-12.5
x | P/E ratio 2025 * |
128
x | Employees | 17,800 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.1% |
Latest transcript on Catalent, Inc.
1 day | +0.22% | ||
1 week | +0.79% | ||
Current month | -0.94% | ||
1 month | -0.60% | ||
3 months | +7.06% | ||
6 months | +42.40% | ||
Current year | +24.46% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 10-09-30 | |
Matti Masanovich
DFI | Director of Finance/CFO | 52 | 23-07-04 |
Lim Chin Wei
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rolf Classon
BRD | Director/Board Member | 79 | 14-07-31 |
John Greisch
CHM | Chairman | 68 | 18-02-15 |
J. Carroll
BRD | Director/Board Member | 74 | 15-07-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 2 M€ | -.--% | ||
1.21% | 8 M€ | +2.44% | ||
0.83% | 2 M€ | +6.77% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 55.92 | +0.22% | 2,846,393 |
24-04-25 | 55.8 | -0.27% | 1,903,179 |
24-04-24 | 55.95 | -0.14% | 2,031,654 |
24-04-23 | 56.03 | -0.04% | 1,575,946 |
24-04-22 | 56.05 | +1.03% | 1,812,494 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.46% | 10.12B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- CTLT Stock